» Articles » PMID: 38690275

Crosstalk Between T Lymphocyte and Extracellular Matrix in Tumor Microenvironment

Overview
Journal Front Immunol
Date 2024 May 1
PMID 38690275
Authors
Affiliations
Soon will be listed here.
Abstract

The extracellular matrix (ECM) is a complex three-dimensional structure composed of proteins, glycans, and proteoglycans, constituting a critical component of the tumor microenvironment. Complex interactions among immune cells, extracellular matrix, and tumor cells promote tumor development and metastasis, consequently influencing therapeutic efficacy. Hence, elucidating these interaction mechanisms is pivotal for precision cancer therapy. T lymphocytes are an important component of the immune system, exerting direct anti-tumor effects by attacking tumor cells or releasing lymphokines to enhance immune effects. The ECM significantly influences T cells function and infiltration within the tumor microenvironment, thereby impacting the behavior and biological characteristics of tumor cells. T cells are involved in regulating the synthesis, degradation, and remodeling of the extracellular matrix through the secretion of cytokines and enzymes. As a result, it affects the proliferation and invasive ability of tumor cells as well as the efficacy of immunotherapy. This review discusses the mechanisms underlying T lymphocyte-ECM interactions in the tumor immune microenvironment and their potential application in immunotherapy. It provides novel insights for the development of innovative tumor therapeutic strategies and drug.

Citing Articles

Tumor secretome shapes the immune landscape during cancer progression.

Yang J, Tang S, Saba N, Shay C, Teng Y J Exp Clin Cancer Res. 2025; 44(1):47.

PMID: 39930476 PMC: 11809007. DOI: 10.1186/s13046-025-03302-0.


Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.

Glaviano A, Lau H, Carter L, Lee E, Lam H, Okina E J Hematol Oncol. 2025; 18(1):6.

PMID: 39806516 PMC: 11733683. DOI: 10.1186/s13045-024-01634-6.


Subverting to Prevent : Alteration of Effector Immune Cell Migration and Adhesion as a Key Mechanism of Tumor Immune Evasion.

Mastrogiovanni M, Donnadieu E, Pathak R, Di Bartolo V Biology (Basel). 2024; 13(11).

PMID: 39596815 PMC: 11591779. DOI: 10.3390/biology13110860.


The role of neutrophils in osteosarcoma: insights from laboratory to clinic.

Xia M, Han Y, Sun L, Li D, Zhu C, Li D Front Immunol. 2024; 15:1490712.

PMID: 39582869 PMC: 11582048. DOI: 10.3389/fimmu.2024.1490712.


Panoramic tumor microenvironment in pancreatic ductal adenocarcinoma.

Li X, Hou W, Xiao C, Yang H, Zhao C, Cao D Cell Oncol (Dordr). 2024; 47(5):1561-1578.

PMID: 39008192 DOI: 10.1007/s13402-024-00970-6.

References
1.
Caruana I, Savoldo B, Hoyos V, Weber G, Liu H, Kim E . Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes. Nat Med. 2015; 21(5):524-9. PMC: 4425589. DOI: 10.1038/nm.3833. View

2.
Zeng Y, Gao M, Lin D, Du G, Cai Y . Prognostic and Immunological Roles of MMP-9 in Pan-Cancer. Biomed Res Int. 2022; 2022:2592962. PMC: 8844435. DOI: 10.1155/2022/2592962. View

3.
Mariadoss A, Wang C . Exploring the Cellular and Molecular Mechanism of Discoidin Domain Receptors (DDR1 and DDR2) in Bone Formation, Regeneration, and Its Associated Disease Conditions. Int J Mol Sci. 2023; 24(19). PMC: 10573612. DOI: 10.3390/ijms241914895. View

4.
Deng B, Zhao Z, Kong W, Han C, Shen X, Zhou C . Biological role of matrix stiffness in tumor growth and treatment. J Transl Med. 2022; 20(1):540. PMC: 9682678. DOI: 10.1186/s12967-022-03768-y. View

5.
Li L, Shao M, Peng P, Yang C, Song S, Duan F . High expression of GFAT1 predicts unfavorable prognosis in patients with hepatocellular carcinoma. Oncotarget. 2017; 8(12):19205-19217. PMC: 5386678. DOI: 10.18632/oncotarget.15164. View